Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.23 USD | -3.56% | +1.47% | +45.56% |
09/05 | Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Lantern Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.56% | 67.03M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+44.76% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- HC Wainwright Adjusts Lantern Pharma's Price Target to $36 From $34, Reiterates Buy Rating